Pfizer and Merck have both tested COVID-19 treatments in pill form that each says is effective in preventing severe illness from the virus. Pfizer claims its Paxlovid cut the risk of hospitalization or death by 89 percent when given within three days of patients developing symptoms. Merck, had its pill authorized by the British government.